Ending Medicare Drug Subsidies Could Raise Costs for Consumers
The Trump administration has moved to end subsidies for Medicare Part D prescription drug plans. This decision could lead to higher premiums and out-of-pocket expenses for millions of seniors and people with disabilities. It matters because it may reduce access to affordable medications for vulnerable populations.